Dan Molina

Associate Attorney

Denver

d.molina@vicentellp.com

7195801626

1553 Platte Street
Suite 310
Denver, CO 80202

Administrative Law
Litigation & Arbitration
Regulatory Compliance

Colorado

J.D., University of Denver
MPA, University of Colorado at Colorado Springs
B.A., University of Colorado at Colorado Springs

Overview

Dan Molina is an associate attorney at Vicente LLP's Denver office. He assists the litigation team and collaborates closely with the hemp & cannabinoids and corporate departments on various matters.

Prior to joining Vicente, Dan worked as a hemp farmer in the regulated hemp industry, managing cultivation, harvesting, product development, and sales. He also served nearly five years as a U.S. Army combat medic and continues to teach combat medicine courses in austere environments during his free time.

Dan graduated magna cum laude from the University of Colorado at Colorado Springs with a bachelor’s degree in public law and administration. He later earned his master’s degree in public administration from the same institution. He went on to complete his Juris Doctorate at the University of Denver Sturm College of Law.

Dedicated to service, Dan is a long-standing Pikes Peak United Way Emerging Leaders Council member and works with Trident Defense Initiative in Ukraine to train new combat medics supporting the Ukrainian Army. His passion for the cannabis industry is deeply rooted in his military service and hands-on experience as a hemp farmer.

Experience

Leadership & Community Involvement

  • Member, International Cannabis Bar Association 
  • Chair, International Cannabis Bar Association Events Committee
  • Member, Pikes Peak United Way's Emerging Leaders Council
  • Member, American Legion
  • Member, Veterans of Foreign Wars

Representative Experience

  • Advised clients on revamping websites to ensure compliance with a wide range of state and federal statutes and regulations.
  • Assisted clients in successfully opposing and prevailing against open records requests filed by adverse entities.
  • Guided businesses in the hemp and cannabinoids sector through complex regulatory frameworks, addressing novel and evolving compliance issues.
  • Played a key role in drafting and submitting a comprehensive comment to the U.S. Drug Enforcement Administration regarding cannabis rescheduling to Schedule III and its alignment with international drug treaty obligations.